During morphogenesis, the actin cytoskeleton mediates cell-shape change in response to growth signals. In plants, actin filaments organize the cytoplasm in regions of polarized growth, and the filamentous arrays can be highly dynamic. Small GTPase signaling proteins termed Rho of plants (ROP)/RAC control actin polymerization. ROPs cycle between inactive GDP-bound and active GTPbound forms, and it is the active form that interacts with effector proteins to mediate cytoskeletal rearrangement and cell-shape change. A class of proteins termed guanine nucleotide exchange factors (GEFs) generate GTP-ROP and positively regulate ROP signaling. However, in almost all experimental systems, it has proven difficult to unravel the complex signaling pathways from GEFs to the proteins that nucleate actin filaments. In this article, we show that the DOCK family protein SPIKE1 (SPK1) is a GEF, and that one function of SPK1 is to control actin polymerization via two heteromeric complexes termed WAVE and actin-related protein (ARP) 2/3. The genetic pathway was constructed by using a combination of highly informative spk1 alleles and detailed analyses of spk1, wave, and arp2/3 single and double mutants. Remarkably, we find that in addition to providing GEF activity, SPK1 associates with WAVE complex proteins and may spatially organize signaling. Our results describe a unique regulatory scheme for ARP2/3 regulation in cells, one that can be tested for widespread use in other multicellular organisms.
C
ell morphogenesis occurs in the context of tissue and organ development. In the leaf epidermis, populations of cells regulate the location and extent of cell expansion, primarily through the spatial control of the cytoskeleton and endomembrane systems. Plant cells (1, 2) , like those of other eukaryotes (3, 4) , use Rho family small GTPases as critical signaling proteins to dictate cell-shape change. Rho of plants (ROP) cycles between GTP-bound active forms and GDP-bound inactive forms, and the nucleotide status of ROP is subject to complex regulation. One class of proteins termed guanine nucleotide exchange factors (GEFs) catalyzes the exchange of bound GDP with the endogenous pool of GTP and positively regulates ROP signaling (2, 4) . GTP-bound ROP physically interacts with diverse classes of effector proteins to control trafficking through the endomembrane system and the organization of the cytoskeleton (5) (6) (7) . This article defines a complete morphogenetic pathway from ROP activation to actin-related protein (ARP) 2/3-dependent regulation of the actin cytoskeleton.
In the leaf epidermis, three different ROP effectors are known. Interactor of constitutive active ROPs 1 (ICR1) is required for the polarized growth and the normal lobing of pavement cells and appears to link ROP signaling to the exocyst complex and the secretory pathway (7) . Two other genes, Rop-interactive CRIB motif 4 (RIC4) (6) and PIROGI/KLUNKER/PIRP/SRA1 (referred to in this article as SRA1) (5) , are thought to link ROP signaling to actin-dependent polarized growth. The genetic and biochemical functions of SRA1 are well characterized. SRA1 is a conserved protein in both plants and animals and is a WAVE complex protein that directly interacts with active ROP/Rac (5, 8) . In cultured mammalian cells, Sra1 mediates the Racdependent relocalization of the WAVE complex to leading edges of lamellipodia (9) , and in Arabidopsis, SRA1 and the WAVE complex positively regulate an actin filament-nucleating machine, named the ARP2/3 complex (10). Plant and animal WAVE complexes contain SCAR, a potent activator of ARP2/ 3-dependent actin filament nucleation (8, 11) .
In both plant and animal systems, the proteins that generate the ROP/Rac signals and activate the WAVE-ARP2/3 pathway are not known, and in general it has proven difficult to assign clear functional linkages between GEFs and the proteins that directly regulate the cytoskeleton. To our knowledge, a genetic pathway linking a specific GEF to an actin filament nucleator has not been described in any multicellular organism. Progress is hindered by genetic redundancy. For example, vertebrate genomes encode large gene families of Dbl-homology domain and DOCK family RhoGEFs (3, 4) . In other cases, genetic studies of nonredundant GEFs (12) or actin filament nucleators (13) are complicated by extreme pleiotropy and/or embryonic lethality. Genetic studies in Arabidopsis are not immune to such technical barriers. Although plants appear to lack the Dbl-homology domain-containing RhoGEFs that are widespread in animals, the Arabidopsis genome encodes 14 PRONE domain GEFs (14) that can affect the actin cytoskeleton and the tip growth of pollen tubes (15, 16) . Arabidopsis has only a single DOCK family protein, SPIKE1 (SPK1). SPK1 (17) , like all known WAVE and ARP2/3 complex subunit genes (11) , is ubiquitously expressed and, based on the presence of the conserved DOCK homology region 2 (DHR2) domain, SPK1 originally was proposed to positively regulate ROP (17) . Although the phenotype of spk1 plants is quite pleiotropic, the viability of the mutant and its highly diagnostic trichome-swelling phenotype can be used to discover novel morphogenesis pathways.
In this article, we exploit a set of Arabidopsis epidermal morphology mutants termed the ''distorted group'' to define a morphogenesis pathway from the DOCK family GEF SPK1 to the actin filament nucleator ARP2/3. Our genetic and biochemical data indicate that ROP activation is the critical function for SPK1. We find that SPK1 not only generates signals that activate the WAVE-ARP2/3 pathway, but also that the ROP-GEF associates with downstream WAVE complex targets of ROP signaling.
Results
The DOCK family protein SPK1 contains a C-terminal segment that shares amino acid identity with the catalytic domain of DOCK family GEFs (17) (18) (19) . To test for an in vivo importance of SPK1 and its putative GEF domain, termed DHR2 (18) or CDMS (17), we analyzed a spk1-3 allele that truncated Ϸ160 aa from the domain (Fig. 1A) . The mutation caused spk1 null phenotypes ( Fig. 1 B-D) . Compared with the wild-type trichomes, those of spk-1 and spk1-3 showed a reduced branch number and an irregular swelling along the stalk and branches (Fig. 1D) . The null spk1-3 phenotype was not caused by destabilization of the truncated protein, because in whole-cell extracts, spk1-3 accumulated to approximately wild-type levels (Fig. 1E ). Given the highly conserved amino acid sequence and known function of DH2 domains, the above results suggest that positive regulation of ROP is a critical function for SPK1.
We therefore tested the ability of endogenous SPK1 to associate with ROP. In coimmunoprecipitation (coIP) experiments using an antibody directed against SPK1, we found that endogenous SPK1 and ROP associated with each other (Fig.  2A) . DHR2 affected the formation of SPK1-ROP complexes because we failed to detect ROP in coIP experiments using extracts prepared from spk1-3 plants (Fig. 2 A) . DHR2 also mediated the association of SPK1 with ROP in pull-down assays using purified GST-tagged ROPs. The preferential binding to a nucleotide-depleted Rho apoprotein is a hallmark of GEFs (4), and we found that endogenous SPK1 associated with GST-ROP2 in either the nucleotide-depleted or the GDP-bound forms (Fig. 2B) . As expected, the association required an intact DHR2 domain (Fig. 2B) . Furthermore, the interaction was specific to ROP, because SPK1 binding to human Rac was not detected (Fig. 2B ). SPK1 and ROP directly interact because a purified C-terminal fragment of SPK1 (996-DHR2) efficiently sedimented inactive forms of ROP2 (Fig. 2C) . We suspect that the previously reported failure to detect direct interactions between SPK1 and ROP (14) reflects a weakness of the yeast two-hybrid assay.
The Arabidopsis ROP GTPase gene family consists of 11 members (20) , many of which are expressed in the shoot and are candidate targets of SPK1 regulation. We therefore tested the SPK1-binding activity of several shoot-expressed prenylated ROPs (ROP2 to ROP5) and the S-acylated isoform, ROP10 (21) . In triplicate pull-down assays that used full-length recombinant SPK1, there were no significant differences in the strength of SPK1 binding to any of the different ROP isoforms (Fig. 2D) . However, for each of the ROPs tested, SPK1-binding was highly selective for nucleotide-depleted or GDP-bound forms [ Fig. 2D and supporting information (SI) Fig. 5 ]. The ability of SPK1 and 996-DHR2 to bind GDP-ROP is unique compared with other known DOCKs, such as Dock180 and Zizimin (18, 19, 22) . Full-length recombinant SPK1 has GEF activity. The intrinsic rate of ROP2 nucleotide exchange was slow with an apparent off-rate of bound nucleotide (k obs ) of 0.03 min Ϫ1 , and SPK1 accelerated the nucleotide exchange reaction Ϸ7-fold (Fig. 2E) , with k obs ϭ 0.21 min Ϫ1 . Insect extracts containing an irrelevant expressed protein had no effect on the reaction kinetics (Fig.  2E ). The DHR2 domain is sufficient for GEF activity because purified 996-DHR2 accelerated nucleotide exchange Ϸ4-fold (k obs ϭ 0.13 min Ϫ1 ), and the activity increased in a concentration-dependent manner (Fig. 2F ). The nucleotide exchange activity of 996-DHR2 is at least as strong as those reported for DHR2 fragments from Dock180 and Zizimin1 (18, 19) . SPK1 catalysis was not limited to ROP2 as a substrate. The full-length protein accelerated nucleotide exchange when tested with ROP3, ROP4, and ROP6 (SI Fig. 6 ). Together, these biochemical data suggest that endogenous SPK1 is sufficient to bind and activate endogenous ROP.
The trichome phenotypes of spk1 provide an opportunity to identify additional genes that couple SPK1 GEF activity to a cytoskeletal response. Spk1 Ϫ trichomes often are swollen and short (Figs. 1D and 3 A and F). These phenotypes resemble those of the ''distorted group,'' which is a set of mutants that corresponds to WAVE and ARP2/3 subunit-encoding genes (10) . Like the distorted mutants (23, 24) , the reduced length and irregular swelling of spk1 are relatively insensitive to actin-depolymerizing drugs such as latrunculin B (LatB) (Fig. 3E) . A reduced trichome branch number does not preclude LatB-induced swelling, because the drug clearly enhanced the cell swelling of gl3 and qualitatively phenocopied spk1 trichomes (Fig. 3C ). The cytoskeleton defects in swollen spk1 branches also are consistent with an ARP2/3-related component to the phenotype. Unlike early-stage wild-type branches that contained a population of cytoplasmic actin filaments and bundles that extended toward the branch apex, similarly staged swollen spk1 branches failed to generate or maintain such an array (Fig. 3B ). As reported (5, 25) , sra1 trichome branches also have disorganized core actin filaments (Fig. 3B) . Spk Ϫ shared several additional phenotypes with wave and arp2/3 mutants, including defective pavement cell-cell adhesion (Fig. 1C) and a reduced length and cell-cell adhesion in etiolated hypocotyls (SI Fig. 7 and SI Table 1 ), further suggesting that these genes function in a common pathway.
To test directly for SPK1 and SRA1 functions in a common pathway, we constructed double mutants and used trichome height and a shape descriptor for cell swelling to quantitate cell-shape phenotypes. If SPK1 and SRA1 function in independent growth pathways, then we would expect the double mutant to display a phenotype that is more severe than spk1 alone. However, the cell height and swelling phenotypes of spk1 sra1 were indistinguishable from those of spk1 alone (Fig. 3 E and F) , indicating that the genes function in a common pathway. Our trichome shape assays resolved genes that function in SRA1-independent pathways because gl3 sra1 (Fig. 3 C and D) and sti sra1 (SI Fig. 8 and SI Table 2 ) trichomes were significantly shorter and more swollen compared with gl3 and sti alone. The double mutants also revealed independent trichome functions for both SPK1 and SRA1. As expected, in spk1 sra1, the reduced branch number phenotype of spk1 was independent of SRA1 ( Fig. 3 A and E) . Along similar lines, distorted mutants have a cell-twisting component to their trichome phenotype. Spk1 Ϫ trichomes do not twist ( Fig. 1D and 3A) , but as expected, the twisting phenotype of sra1 was apparent in a double mutant combination with spk1 ( Fig. 3E) and gl3 (Fig. 3C) .
These genetic data indicate that SPK1 and SRA1 function in a common pathway that prevents cell swelling and suggest that SPK1-dependent activation of ROP is the primary mechanism of SRA1 activation. However, the connectivity and specificity of the 
SPK1-ROP-SRA1
pathway is not clear, because SPK1 appears to bind and activate ROPs promiscuously. Importantly, SRA1 may associate with active ROPs with a greater degree of isoform specificity (5). In GST pull-down assays, SRA1 consistently bound most strongly to GTP-ROP2 and GTP-ROP4 (Fig. 4A) . SRA1 had weaker physical interactions with GTP-ROP3 and GTP-ROP6, and no binding to ROP5 and ROP10 was detected even though they were active proteins, because both ROPs associated with MBP-RIC1 with nucleotide selectivity (Fig. 4A) .
To learn more about the coupling of SPK1, ROP, and WAVE activities, we tested for physical associations between SPK1 and WAVE complex proteins. GEFs have been reported to physically interact with putative effector proteins (26) , and it is possible that SPK1 could increase signaling specificity by associating with components of the WAVE complex. Our SRA1 antibodies did not detect the endogenous protein in Western blots. However, NAP1 is a useful surrogate for SRA1 because the plant proteins physically interact with high affinity (27) , and in vertebrate cells Sra1 and Nap1 copurify (8) . Immunoprecipitates of solubilized endogenous SPK1 contained the WAVE complex protein NAP1 (Fig. 4B) . The association of SPK1 and NAP1 is specific because NAP1 was not detected in preimmune serum coIP fractions, and only background signals were obtained when spk1-1 extracts were used as the source of proteins (Fig. 4B) . These data indicate that at least some fraction of endogenous SPK1 and NAP1 exist as a complex. As an independent test for an association of SPK1 with WAVE complex proteins, we analyzed the size of detergent-solubilized SPK1 complexes isolated from wild-type, sra1, and nap1 strains (Fig.  4C) . If a significant pool of SPK1 associates with SRA1 (145 kDa) and/or NAP1 (149 kDa), then we would expect SPK1 complexes to shift to lower mass fractions in the mutant backgrounds. In wild-type extracts, SPK1 complexes had a mean apparent mass of 660 kDa and were distributed normally across three gel-filtration fractions. Even after overexposure of Western blots, SPK1 signal was restricted to these three fractions. In the sra1 background, the apparent mass of SPK1 complexes was clearly reduced, and SPK1 was consistently observed also in a 280-kDa fraction (Fig. 4C) . Removal of NAP1 had a more subtle effect on SPK1. In nap1, the peak fraction for SPK1 was reproducibly shifted to a mean apparent mass of 530 kDa, and SPK1 signal in 340-kDa fractions was consistently detected (Fig.  4C) . The more severe effects of sra1, compared with nap1, on the size distribution of SPK1 complexes may reflect a more prominent role for SRA1 in the recruitment or stabilization of SPK1 complex proteins, including its binding partner NAP1. The association of endogenous SPK1 with WAVE complex proteins is consistent with the hypothesis that SPK1 directly regulates the WAVE-ARP2/3 pathway and presents a possible mechanism to generate signaling specificity.
Discussion
In this article, we report on the discovery of a morphogenetic pathway in which the ROP-GEF SPK1 positively regulates actin-dependent morphogenesis through the heteromeric WAVE and ARP2/3 complexes. The pathway was constructed by using informative null alleles, clear genetic interactions, and biochemical activities of pathway components. The basic regulatory scheme is clear. SPK1 is a GEF that generates GTP-ROP. SRA1 is one target of SPK1 signaling, and through unknown mechanisms, SRA1 translates GTP-ROP signals into positive regulation of the ARP2/3 complex during actin-dependent growth. This pathway controls numerous aspects of plant development (25) and presents an important opportunity to understand how cellular activities are coordinated during growth.
Our genetic analyses strongly support the existence of a SPK1-WAVE-ARP2/3 pathway. First, the similar array of spk1, wave, and arp2/3 phenotypes suggests common functions. Spk1 Ϫ trichomes, unlike those of other reduced branching mutants sti and gl3, are swollen and not noticeably affected by actindepolymerizing drugs, and the actin cytoskeleton is disorganized in apical regions of elongating cells. In addition spk1, wave, and arp2/3 mutants display reduced pavement cell-cell adhesion and indistinguishable hypocotyl elongation defects-all defining features of the distorted group mutants (10) . Our double mutant analysis of spk1 sra1 indicates clearly that SPK1 and the ROP signaling target SRA1 function in a common pathway, because the trichome swelling and cell elongation defects of spk1 are indistinguishable from those of the double mutant.
Our results provide clear insight into the regulatory relationships between SPK1 and the WAVE complex. We find that the conserved DHR2 domain of SPK1 provides critical GEF activity. Truncation of the domain causes a spk1 null phenotype and affects the ability of endogenous SPK1 to associate with ROP in both coIP and GST-ROP pull-down assays. We also find that the purified DHR2 domain is sufficient for ROP-binding and GEF activity. Significantly, we detect stable physical associations of full-length recombinant SPK1 and purified DHR2 with GDP-ROP, which is the physiologically relevant form of inactive ROP. Vertebrate DOCK family proteins such as Dock180 and Zizimin bind strongly only to nucleotide-depleted GTPase (18, 19, 22) , and the ELMO proteins increase DOCK-mediated GEF activity (28) . Our results suggest that SPK1 is sufficient for GEF activity, and based on the null phenotype of the spk1-3 DHR2 truncation allele, the primary function of SPK1 may be to provide GEF activity. Interestingly, SPK1 binds to and activates ROPs promiscuously in vitro, suggesting that the biochemical selectivity of SPK1 for particular ROPs is not a major contributor to signaling specificity. The situation is quite different with vertebrate DOCKs. Nonplant DOCK GEFs display strong selectivity for Rac1 or Cdc42, and in these cases, the biochemical data correlate with in vivo signaling specificity (18, 19) . It is possible that SRA1, the likely target of SPK1 signaling, contributes to ROP signaling specificity. Among the ROPs tested, SRA1 preferentially binds to ROP2 and ROP4, and this selectivity may limit the responsiveness of the WAVE complex to particular ROP signals. Clearly, further research is needed to determine whether particular ROPs function downstream of SPK1 and how signaling specificity is achieved.
In addition to generating ROP activation signals, SPK1 associates with downstream WAVE complex signaling targets. The binding of GEFs to their signaling effectors has been hypothesized as a general strategy to achieve specificity (3), and we provide strong support for such a regulatory scheme in the SPK1-WAVE-ARP2/3 pathway. In coIP experiments, we find that detergent-solubilized SPK1 complexes also contain the WAVE complex protein NAP1. It also is clear that the apparent mass of SPK1 complexes is reduced when isolated from nap1 or sra1 null plants. The recent report of yeast two-hybrid interactions between SPK1 and WAVE complex proteins is consistent with our results (29) . It therefore is possible that SPK1 both generates and organizes ROP signaling. Interestingly, we find that overexpression of a constitutively active ROP2 (CA-ROP2) (30) does not bypass the requirement for SPK1, because CA-ROP2 spk1 plants have completely additive phenotypes when compared with the individual spk1 and CA-ROP2 lines. Perhaps additional ROPs are needed to activate the WAVE and ARP2/3 complexes. Alternatively, the subcellular location of ROP activation and/or the tight spatial coupling of ROP activation and its effector proteins are critical. Rac signaling can affect the composition (8) and the dynamic subcellular localization of WAVE complexes (9) . SPK1 may define more precisely the location(s) of WAVE complex activation and/or the efficiency with which the WAVE complex proteins cycle through rounds of activation, use, and retrieval. Along these lines, it will be important to understand not only how ROP activation affects the association of WAVE complex proteins with SPK1 but also the downstream functions of WAVE and ARP2/3 during cell morphogenesis.
Although the results above firmly establish the existence of a SPK1-WAVE-ARP2/3 pathway, the components of this pathway are certain to have additional independent functions (SI Fig.  9 ). For example, the pavement cell and leaf shape defects of spk1 are much more severe than those of wave and arp2/3 mutants (5, 17, 31) . Even in trichomes, SPK1 is likely to have WAVE-ARP2/ 3-independent functions based on a reduced branch number phenotype that is not linked to an actin filament defect (24) . Independent functions for WAVE-ARP2/3 also are apparent because distorted trichome mutants have a cell-twisting phenotype that is not observed in spk1 trichomes. Therefore, the WAVE-ARP2/3 pathway controls coherent (nontwisting) cell elongation, and additional positive regulators of SRA1 and the WAVE complex remain to be discovered (SI Fig. 9 ). We expect the shared and independent functions of SPK1 and WAVE-ARP2/3 to provide insight into how diverse cellular activities are integrated during morphogenesis. In conclusion, this article demonstrates that the SPK1 DHR2 domain and its associated GEF activity generates ROP signals that positively regulate ARP2/3 and actin filament nucleation. SPK1 shares amino acid identity with DOCK family GEFs in several regions (17) , and the fact that human and Arabidopsis WAVE complex proteins can function interchangeably (5, 27) suggests that the DOCK-WAVE-ARP2/3 pathway we describe here may be widely used in other multicellular organisms. Further study of SPK1 will continue to provide mechanistic knowledge about the architecture and regulation of evolutionarily conserved cell-shape control pathways.
Materials and Methods
Plant Strains, Growth Conditions, and Morphometry. For all experiments, the accession Col-0 was used as wild type. The spk1-1 and spk1-2 alleles are described in ref. 17 . spk1-3 is a TILLING allele (32) and was backcrossed four times before use. For all experiments, the null allele of sra1 is pir-3 (5). Cotyledon measurements and scanning electron microscopy (SEM) were conducted as described in ref. 17 . For trichome morphometry, orthogonal views were used to measure the length, perimeter, and area. Swelling factor [36 ϫ (area)/ ͌ 3 ϫ (perimeter) 2 )] is a dimensionless shape descriptor that we adapted to trichomes by using the equilateral triangle as the reference shape. The randomly positioned sra1 trichome branches precluded its inclusion in the double mutant analysis.
coIP and Size-Exclusion Chromatography. To prepare plant extracts, 2 g of shoot tissue at 15 days after germination (DAG) was homogenized, solubilized, and clarified as described in SI Methods. For coIP, 700 g of cell extracts were added to coIP buffer (20 mM Hepes/KOH, pH 7.2/150 mM NaCl/1% Nonidet P-40/0.1% SDS) containing 15 g of ␣-SPK1N antibody or preimmune serum bound to protein A beads (Pierce). The protein A bound fractions were washed extensively and probed with ␣-SPK1N, ␣-NAP1, or ␣-ROP antibodies at dilutions of 1:1,000, 1:250, and 1:1,000, respectively. For size-exclusion chromatography, solubilized SPK1 fractions were separated on a Sephadex 200 HR 10/300 column (GE Healthcare). The column fractions were precipitated and analyzed by Western blotting using the ␣-SPK1N antibody. Gel-filtration experiments were repeated at least two times for each genotype.
Recombinant Protein Expression and Quantification. The construction of expression plasmids is described in SI Methods, and PCR primers used are described in SI Table 3 . For expression and purification of the GST-996-DHR2 protein and HIS-SRA1, pDS15-996-DHR2 and pDS17-PIR(SRA1) plasmids were transformed into Escherichia coli Rosetta (DE3) strain (Novagen) and induced at OD 600 ϭ 0.6 -0.7 and then grown at 37°C for 4 h. Soluble proteins were purified by using glutathione beads (Sigma-Aldrich) and Ni 2ϩ beads (Novagen) according to the manufacturer's specifications. Full-length recombinant SPK1 was expressed by using the Bac-to-Bac SF9 insect cell expression system (Invitrogen). The concentration of SPK1 in the crude insect extracts was quantified by using a dot-blot assay with a purified SPK1 N-terminal protein fragment as a standard. The active fraction of recombinant full-length SPK1 and GST-996-DHR2 used in GEF assays was calculated based on the proportions of these proteins that bound to saturating amounts of nucleotidedepleted ROP2 in pull-down assays. See SI Methods for a description of the nucleotide-binding assay and GEF assay methodology.
Protein Pull-Down Experiments. For the GST-ROP pull-down assay using plant extracts, 3 M bead-bound GST-ROP2 was mixed with 200 g of soluble plant protein extract. The binding reactions were incubated at room temperature for 2 h. After extensive washing, the bead-bound fractions were probed with the ␣-SPK1N antibody. The GST-ROP pull-down assays with insect-expressed SPK1 used similar methods. For GST pull-down assays with GST-996-DHR2, 0.2 M nucleotide-loaded HIS-ROP2 was incubated with bead-bound 0.05 M GST-996-DHR2 for 2 h at room temperature, and the bead-bound fractions were probed with an ␣-ROP antibody.
